|
인쇄하기
취소
|
Dendritic cells-based immunotherapy to be commercialized next year
Published: 2004-04-06 06:55:00
Updated: 2004-04-06 06:55:00
Keunwha Pharm said recently that its dendritic cells-based immunotherapy, which was developed in collaboration with Binex and research team of Pusan University last November, is to be launched next year after completion of Phase I/II clinical trials following the approval from the Korea Food and Drug Administration. The company is contemplating further clinical trials for the additional indicat...
Fees
- Email service daily and homepage access.
- $300 per month.
- 5 Email holders per each company.
- Anual contract base.
Copyright Yakup.com All rights reserved.
약업닷컴의 모든 컨텐츠는 저작권법의 보호를 받습니다. 무단 전재⋅복사⋅배포 등을 금합니다.